http://fasb.org/us-gaap/2024#其他長期資產http://fasb.org/us-gaap/2024#其他長期資產http://fasb.org/us-gaap/2024#其他流動負債http://fasb.org/us-gaap/2024#其他流動負債http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent0001039065--06-302025Q1錯誤0000錯誤錯誤錯誤錯誤錯誤錯誤http://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrMember0001039065US-GAAP:普通股成員2024-09-300001039065us-gaap:留存收益成員2024-09-300001039065us-gaap:其他綜合收益的累計成員2024-09-300001039065us-gaap:留存收益成員2024-06-300001039065us-gaap:其他綜合收益的累計成員2024-06-300001039065us-gaap:留存收益成員2023-09-300001039065us-gaap:其他綜合收益的累計成員2023-09-300001039065us-gaap:留存收益成員2023-06-300001039065us-gaap:其他綜合收益的累計成員2023-06-300001039065美國通用會計原則:普通股,包括額外已付股本的成員2024-09-300001039065美國通用會計原則:普通股,包括額外已付股本的成員2024-06-300001039065美國通用會計原則:普通股,包括額外已付股本的成員2023-09-300001039065美國通用會計原則:普通股,包括額外已付股本的成員2023-06-300001039065US-GAAP:員工股票期權成員2024-06-300001039065srt:AsiaPacificMember2024-09-300001039065美國通用會計原則限制性股票單位累計成員2024-06-300001039065country:US2024-07-012024-09-300001039065country:US2023-07-012023-09-3000010390652024-10-012024-09-300001039065us-gaap:設施關閉成員。2024-09-300001039065us-gaap:EmployeeSeveranceMember2024-09-300001039065與收購相關的費用成本的美國通用會計準則2024-09-300001039065srt:MaximumMember2024-09-300001039065us-gaap:設施關閉成員。2024-06-300001039065us-gaap:EmployeeSeveranceMember2024-06-300001039065與收購相關的費用成本的美國通用會計準則2024-06-300001039065srt:MaximumMember2024-06-300001039065us-gaap:租賃改善成員2024-09-300001039065美國通用會計準則:土地成員2024-09-300001039065us-gaap:傢俱和固定資產會員2024-09-300001039065us-gaap:設備會員2024-09-300001039065在建工程2024-09-300001039065us-gaap:ComputerSoftwareIntangibleAssetMember2024-09-300001039065美國通用會計準則:計算機設備成員2024-09-300001039065US-GAAP:建築和建築改良會員2024-09-300001039065us-gaap:NonqualifiedPlanMember2024-09-300001039065us-gaap:租賃改善成員2024-06-300001039065美國通用會計準則:土地成員2024-06-300001039065us-gaap:傢俱和固定資產會員2024-06-300001039065us-gaap:設備會員2024-06-300001039065在建工程2024-06-300001039065us-gaap:ComputerSoftwareIntangibleAssetMember2024-06-300001039065美國通用會計準則:計算機設備成員2024-06-300001039065US-GAAP:建築和建築改良會員2024-06-300001039065us-gaap:NonqualifiedPlanMember2024-06-300001039065srt:ChiefExecutiveOfficerMember2024-07-192024-07-190001039065us-gaap:其他綜合收益的累計成員2024-07-012024-09-300001039065us-gaap:其他綜合收益的累計成員2023-07-012023-09-300001039065us-gaap:運營業務細分會員us-gaap:OperatingSegmentsMember2024-07-012024-09-300001039065us-gaap:運營業務細分會員srt:MinimumMember2024-07-012024-09-300001039065跨業務板塊清算成員2024-07-012024-09-300001039065us-gaap:企業非部門會員2024-07-012024-09-300001039065us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2024-07-012024-09-300001039065us-gaap:運營業務細分會員us-gaap:OperatingSegmentsMember2023-07-012023-09-300001039065us-gaap:運營業務細分會員srt:MinimumMember2023-07-012023-09-300001039065跨業務板塊清算成員2023-07-012023-09-300001039065us-gaap:企業非部門會員2023-07-012023-09-300001039065us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2023-07-012023-09-300001039065us-gaap:企業成員2023-07-012023-09-300001039065srt:最小成員us-gaap: 循環信貸設施成員2024-09-300001039065us-gaap: 循環信貸設施成員2024-09-300001039065osis:CustomerTwoMember2024-09-300001039065美國公認會計原則:授信額度成員2024-09-300001039065us-gaap:CustomerConcentrationRiskMember2024-09-300001039065us-gaap:商標會員2024-09-300001039065us-gaap:商標會員2024-06-300001039065us-gaap:OperatingSegmentsMember2024-07-012024-09-300001039065srt:MinimumMember2024-07-012024-09-300001039065us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2024-07-012024-09-300001039065us-gaap:OperatingSegmentsMember2024-09-300001039065srt:MinimumMember2024-09-300001039065us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2024-09-300001039065us-gaap:OperatingSegmentsMember2024-06-300001039065srt:MinimumMember2024-06-300001039065us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2024-06-300001039065us-gaap:軟件和軟件開發成本會員2024-09-300001039065專利成員2024-09-300001039065us-gaap:已開發技術權益成員2024-09-300001039065osis:SecurityDivisionMember2024-09-300001039065us-gaap:軟件和軟件開發成本會員2024-06-300001039065專利成員2024-06-300001039065us-gaap:已開發技術權益成員2024-06-300001039065osis:SecurityDivisionMember2024-06-300001039065美國通用會計原則限制性股票單位累計成員2024-07-012024-09-300001039065US-GAAP:員工股票期權成員2024-07-012024-09-300001039065美國通用會計原則限制性股票單位累計成員2024-09-300001039065US-GAAP:員工股票期權成員2024-09-300001039065美國通用會計準則:外匯遠期成員2024-09-300001039065美國通用會計準則:外匯遠期成員2024-06-300001039065 2024-09-300001039065 2024-06-300001039065srt:ChiefExecutiveOfficerMember2024-07-310001039065OSIS:指定期間之後連續五個工作日會員2024-07-012024-09-300001039065OSIS:2024年9月30日結束的季度之後的日曆季度會員2024-07-012024-09-300001039065srt:ChiefExecutiveOfficerMember2024-07-012024-09-300001039065srt:最小成員us-gaap: 循環信貸設施成員2024-07-012024-09-300001039065srt:最大成員us-gaap: 循環信貸設施成員2024-07-012024-09-300001039065us-gaap: 循環信貸設施成員2024-07-012024-09-300001039065us-gaap:服務成員2024-07-012024-09-300001039065US GAAP: 產品成員2024-07-012024-09-300001039065us-gaap:服務成員2023-07-012023-09-300001039065US GAAP: 產品成員2023-07-012023-09-300001039065us-gaap:FairValueInputsLevel2Member2024-09-300001039065srt:ChiefExecutiveOfficerMember2024-09-300001039065奧斯斯:私人無線電頻技術提供商會員2024-09-300001039065us-gaap:FairValueMeasurementsRecurringMember美國通用會計原則:應收賬款成員us-gaap:客戶集中度風險成員us-gaap:OperatingSegmentsMember2024-07-012024-09-300001039065srt:AsiaPacificMember美國通用會計原則:應收賬款成員us-gaap:客戶集中度風險成員us-gaap:OperatingSegmentsMember2024-07-012024-09-300001039065osis:沒有客戶會員美國通用會計原則:應收賬款成員us-gaap:客戶集中度風險成員2024-07-012024-09-300001039065osis:沒有客戶會員美國通用會計原則:應收賬款成員us-gaap:客戶集中度風險成員2023-07-012024-06-300001039065us-gaap:FairValueMeasurementsRecurringMember美國通用會計準則:淨銷售收入會員us-gaap:客戶集中度風險成員us-gaap:OperatingSegmentsMember2023-07-012023-09-3000010390652023-09-3000010390652023-06-300001039065us-gaap:軟件和軟件開發成本會員2024-01-012024-09-300001039065us-gaap:軟件和軟件開發成本會員2023-01-012023-09-300001039065srt:MinimumMember2024-07-012024-09-300001039065srt:MinimumMember2023-07-012023-09-300001039065奧西斯:提供重要軍事空間和監視解決方案的私營公司成員2024-07-012024-09-300001039065美國公認會計原則(US-GAAP):公允價值輸入級別3成員us-gaap:重複計量公允價值會員2024-09-300001039065美國公認會計原則(US-GAAP):公允價值輸入級別3成員us-gaap:重複計量公允價值會員2024-06-300001039065us-gaap:一系列不重要的營業收購2024-09-300001039065xbrli:shares2023-10-310001039065iso4217:USD2023-12-012023-12-310001039065xbrli:shares2023-10-012023-10-310001039065us-gaap:OperatingSegmentsMember2024-07-012024-09-300001039065其他運營效率活動成員2024-07-012024-09-300001039065us-gaap:OperatingSegmentsMember2023-07-012023-09-300001039065其他運營效率活動成員2023-07-012023-09-300001039065us-gaap:運營業務細分會員us-gaap:OperatingSegmentsMember2024-09-300001039065us-gaap:運營業務細分會員srt:MinimumMember2024-09-300001039065跨業務板塊清算成員2024-09-300001039065us-gaap:企業非部門會員2024-09-300001039065us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2024-09-300001039065us-gaap:運營業務細分會員us-gaap:OperatingSegmentsMember2024-06-300001039065us-gaap:運營業務細分會員srt:MinimumMember2024-06-300001039065跨業務板塊清算成員2024-06-300001039065us-gaap:企業非部門會員2024-06-300001039065us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2024-06-300001039065srt:ChiefExecutiveOfficerMember2024-07-012024-09-300001039065銷售總費用成員2024-07-012024-09-300001039065US-GAAP:研發費用成員2024-07-012024-09-300001039065美國通用會計準則:銷售成本成員2024-07-012024-09-300001039065銷售總費用成員2023-07-012023-09-300001039065US-GAAP:研發費用成員2023-07-012023-09-300001039065美國通用會計準則:銷售成本成員2023-07-012023-09-300001039065us-gaap:留存收益成員2024-07-012024-09-300001039065美國通用會計原則:普通股,包括額外已付股本的成員2024-07-012024-09-300001039065us-gaap:留存收益成員2023-07-012023-09-300001039065美國通用會計原則:普通股,包括額外已付股本的成員2023-07-012023-09-300001039065srt:最小成員osis:提供關鍵軍事空間和監視解決方案的私營公司成員2024-09-012024-09-300001039065srt:最大成員osis:提供關鍵軍事空間和監視解決方案的私營公司成員2024-09-012024-09-300001039065US-GAAP:普通股成員2022-09-300001039065srt:最小成員country:US2024-07-012024-09-300001039065srt:最大成員country:US2024-07-012024-09-300001039065美國通用會計原則限制性股票單位累計成員srt:AsiaPacificMember2024-07-012024-09-300001039065us-gaap:設施關閉成員。2024-07-012024-09-300001039065us-gaap:EmployeeSeveranceMember2024-07-012024-09-300001039065與收購相關的費用成本的美國通用會計準則2024-07-012024-09-300001039065srt:MaximumMember2024-07-012024-09-300001039065srt:最大成員us-gaap: 循環信貸設施成員2024-09-300001039065us-gaap:FairValueInputsLevel2Memberus-gaap:重複計量公允價值會員2024-09-300001039065us-gaap:重複計量公允價值會員2024-09-300001039065us-gaap:FairValueInputsLevel2Memberus-gaap:重複計量公允價值會員2024-06-300001039065us-gaap:重複計量公允價值會員2024-06-3000010390652023-07-012023-09-300001039065srt:ChiefExecutiveOfficerMember2024-07-012024-07-310001039065srt:ChiefExecutiveOfficerMember2024-09-3000010390652024-09-3000010390652024-06-300001039065美國通用會計原則:應收賬款成員us-gaap:OperatingSegmentsMember2024-07-012024-09-300001039065美國通用會計準則:淨銷售收入會員2024-07-012024-09-300001039065美國通用會計原則:應收賬款成員2023-07-012024-06-300001039065osis:提供關鍵軍事空間和監視解決方案的私人持有提供者會員2024-09-300001039065osis:提供關鍵軍事空間和監視解決方案的私人持有提供者會員2024-09-012024-09-3000010390652024-10-2100010390652024-07-012024-09-30xbrli:股份iso4217:美元指數xbrli:純形客戶iso4217:美元指數xbrli:股份D細分

目錄

美國
證券交易委員會

華盛頓特區20549

表格10-Q

(標記一)

根據1934年證券交易法第13或15(d)條,本季度報告

截至季度結束日期的財務報告2024年9月30日

或者

根據1934年證券交易法第13或15(d)條的轉型報告

過渡期從             到               

委員會文件號 000-23125

Graphic

致富金融(臨時代碼)系統公司,公司。

(根據其章程規定的註冊人準確名稱)

特拉華州

    

33-0238801

(國家或其他管轄區的
公司成立或組織)

(IRS僱主
唯一識別號碼)

請在對勾內選擇是否註冊人(1) 在過去12個月內按照1934年證券交易所法第13條或15(d)條的規定提交了所有需要提交的報告(或者對於註冊人需要提交這些報告的較短期間),以及(2) 在過去的90天內一直受到這些提交要求的約束。

霍桑, 加利福尼亞州 90250

(總部地址)(郵政編碼)

(310) 978-0516

(註冊人電話號碼,包括區號)

無數據

(前名稱、地址及財政年度,如果自上次報告以來有更改)

在法案第12(b)條的規定下注冊的證券:

每一類的名稱

    

交易標誌

    

在其上註冊的交易所的名稱

普通股,每股0.001美元面值

OSIS

本基金尋求於東歐地區註冊的主要權益關聯發行人的長期升值投資。納斯達克資本市場全球貨幣選擇市場

請在以下勾選,並註明是否爲以下兩項:(1)在過去12個月內(或註冊者需要提交此類報告的較短期間內)提交所有必須提交的根據1934年證券交易法第13或第15(d)條規定提交的報告,並且(2)在過去90天內受到此類提交要求的要求。(小型報告公司) 

請在以下勾選方框表示註冊人是否已在Regulation S-T Rule 405規定的前12個月(或在註冊人需要提交此類文件的較短期間內)提交了每個互動數據文件。

請勾選標記以說明註冊人是大型快速申報人、加速申報人、非加速申報人、較小的報告公司還是新興成長型公司。請查看《交易所法》第120億.2條中「大型快速申報人」、「加速申報人」、「較小的報告公司」和「新興成長型公司」的定義。

大型加速報告人 

   

如果是新興增長公司,請勾選是否註冊人選擇不使用執行交易所第13(a)條規定所提供的任何新的或修訂的財務會計準則的推遲過渡期。 ☐

非加速歸檔企業

小型報表公司

新興成長公司

如果是新興成長型企業,請勾選複選標記,表明註冊者已選擇不使用延長過渡期來符合根據證券交易法第13(a)條規定提供的任何新財務會計準則。

請勾選表示註冊申報人是否爲外殼公司(根據交易所12b-2號規則定義)。是

截至2024年10月21日,有 16,710,749 股普通股股票。

目錄

致富金融(臨時代碼)系統公司,公司。

指數

頁碼

第I部分—財務信息

3

項目1—

基本報表(未經審計)

3

2024年6月30日和2024年9月30日的簡明綜合資產負債表

3

截至2023年和2024年9月30日爲止三個月的簡明綜合損益表

4

截至2023年和2024年9月30日爲止三個月的簡明綜合收益表

5

截至2023年和2024年9月30日爲止三個月的簡明綜合股東權益表

6

截至2023年和2024年9月30日的精簡合併現金流量表 2023年和2024年9月30日結束的三個月

7

壓縮合並財務報表附註

8

項目2—

分銷計劃

23

項目3—

市場風險的定量和定性披露

28

項目 4 —

控制和程序

29

第二部分——其他信息

30

項目 1 —

法律訴訟

30

項目1A—

風險因素

30

項目2—

未註冊的股票股權銷售和籌款用途

30

項目3—

對優先證券的違約

30

項目4—

礦山安全披露

30

項目5 -

其他信息

30

項目6 -

展示資料

31

簽名

32

2

目錄

第一部分—財務信息

第 1 項。財務報表

OSI 系統公司和子公司

簡明合併資產負債表(未經審計)

(金額以千計,股份金額和麪值除外)

6月30日

9月30日

    

2024

    

2024

資產

流動資產:

現金和現金等價物

$

95,353

$

85,053

應收賬款,淨額

 

648,155

687,610

庫存

 

397,939

456,030

預付費用和其他流動資產

 

74,077

81,310

流動資產總額

 

1,215,524

1,310,003

財產和設備,淨額

 

113,967

124,613

善意

 

351,480

381,444

無形資產,淨額

 

139,529

183,222

其他資產

 

115,508

114,232

總資產

$

1,936,008

$

2,113,514

負債和股東權益

流動負債:

銀行信貸額度

$

384,000

$

259,000

長期債務的當前部分

 

8,167

8,217

應付賬款

 

191,149

191,932

應計工資和相關費用

 

46,732

41,048

來自客戶的預付款

 

53,431

63,996

其他應計費用和流動負債

 

131,158

148,343

流動負債總額

 

814,637

712,536

長期債務,淨額

 

129,383

468,084

其他長期負債

 

128,505

146,399

負債總額

 

1,072,525

1,327,019

承付款和或有開支(注10)

股東權益:

優先股,$0.001 面值—10,000,000 已授權股份;未發行或流通股份

 

普通股,$0.001 面值—100,000,000 已獲授權;已發行和流通的股份, 17,055,497 2024 年 6 月 30 日的股票以及 16,710,749 截至 2024 年 9 月 30 日的股票

 

24,289

17

留存收益

 

861,230

810,553

累計其他綜合虧損

 

(22,036)

(24,075)

股東權益總額

 

863,483

786,495

負債和股東權益總額

$

1,936,008

$

2,113,514

參見簡明合併財務報表的附註。

3

目錄

OSI 系統公司和子公司

簡明合併運營報表(未經審計)

(金額以千計,每股數據除外)

截至9月30日的三個月

    

2023

    

2024

淨收入:

產品

$

199,709

$

255,808

服務

 

79,501

88,199

淨收入總額

 

279,210

344,007

銷售商品的成本:

產品

 

136,983

170,422

服務

 

43,482

52,083

銷售商品的總成本

 

180,465

222,505

毛利潤

 

98,745

121,502

運營費用:

銷售、一般和管理

 

59,798

72,223

研究和開發

 

15,922

17,773

重組和其他費用,淨額

 

466

1,178

運營費用總額

 

76,186

91,174

運營收入

 

22,559

30,328

利息和其他費用,淨額

 

(5,748)

(7,359)

所得稅前收入

 

16,811

22,969

所得稅準備金

 

(3,932)

(5,033)

淨收入

$

12,879

$

17,936

每股收益:

基本

$

0.77

$

1.07

稀釋

$

0.75

$

1.05

每股計算中使用的股份:

基本

 

16,825

16,742

稀釋

 

17,175

17,055

參見簡明合併財務報表的附註。

4

目錄

OSI SYSTEMS,INC.及附屬公司

基本報表綜合損益表(未經審計)

(金額以千爲單位)

    

截至9月30日,三個月的結束

    

2023

    

2024

淨利潤

$

12,879

$

17,936

其他綜合收益(損失):

外幣兌換損益,扣除稅金

 

(3,172)

1,181

衍生工具的淨未實現收益(損失),稅後

1,147

(3,220)

其他,稅後淨額。

137

其他綜合損失

(1,888)

(2,039)

綜合收益

$

10,991

$

15,897

請參閱附註事項的簡明合併財務報表。

5

目錄

OSI SYSTEMS,INC.及附屬公司

未經審計的凝聚的股東權益合併報表

(金額以千爲單位,除每股數據外)

2023年9月30日結束的三個月

累積的

普通股

其他

    

股數

    

    

留存收益

    

綜合

    

    

股份

    

數量

    

收益

    

損失

    

總費用

資產負債表—2023年6月30日

 

16,755,772

$

9,835

$

735,957

$

(19,627)

$

726,165

行使股票期權

 

4,752

420

420

限制性股票單位的解除限制

 

363,820

員工股票購買計劃下發行的股票

 

29,813

2,031

2,031

股票補償費用

 

7,089

7,089

與股份獎勵淨結算相關的支付的稅額

 

(166,315)

(19,358)

(2,881)

(22,239)

淨收入

 

12,879

12,879

其他綜合損失

 

(1,888)

(1,888)

資產負債表-2023年9月30日

16,987,842

$

17

$

745,955

$

(21,515)

$

724,457

2024年9月30日結束的三個月

累積的

普通股

其他

    

股數

    

    

留存收益

    

綜合

    

    

股份

    

數量

    

收益

    

損失

    

總費用

結餘-2024年6月30日

17,055,497

$

24,289

$

861,230

$

(22,036)

$

863,483

行使股票期權

957

70

70

限制性股票單位的解除限制

297,418

員工股票購買計劃下發行的股票

31,143

2,329

2,329

股票補償費用

6,422

6,422

回購普通股

(531,314)

(28,919)

(51,524)

(80,443)

與股份獎勵淨結算相關的支付的稅額

(142,952)

(4,174)

(17,089)

(21,263)

淨收入

17,936

17,936

其他綜合損失

(2,039)

(2,039)

資產負債表-2024年9月30日

 

16,710,749

$

17

$

810,553

$

(24,075)

$

786,495

6

目錄

OSI SYSTEMS,INC.及附屬公司

未經審計的簡明合併現金流量表

(金額以千爲單位)

截至9月30日,三個月的結束

    

2023

    

2024

經營活動產生的現金流量

    

淨收入

$

12,879

$

17,936

折舊和攤銷

 

9,568

11,450

股票補償費用

 

7,089

6,422

應收賬款損失的回收

(433)

(427)

延遲所得稅

208

(851)

攤銷債務折扣和發行成本

 

354

其他

 

42

(21)

業務收購前後經營資產和負債的變動:

應收賬款

 

55,868

(30,187)

存貨

 

(82,035)

(54,458)

預付款項和其他資產

 

(7,605)

(23,325)

應付賬款

 

25,851

(4,952)

應計的工資和相關費用

(6,606)

(7,811)

來自客戶預付款

 

10,770

10,267

遞延收入

(7,142)

11,485

其他

 

(1,310)

26,958

經營活動產生的淨現金流量

 

17,144

(37,160)

投資活動產生的現金流量

購置房地產和設備

 

(5,239)

(7,705)

出售固定資產的收益

44

85

存入資金購買存單

(2,068)

來自存單到期的收益

1,839

業務收購,扣除現金收購

 

(75,500)

支付無形資產和其他資產

 

(4,154)

(4,372)

投資活動產生的淨現金流出

 

(9,578)

(87,492)

籌資活動產生的現金流量

銀行信貸額度上的淨借款(還款)

 

20,000

(125,000)

獲得長期債務

 

394

340,475

開多期債償付款

 

(2,073)

(2,078)

行權期權和員工股票購買計劃所得款項

 

2,451

2,399

支付或準備支付的參考負債

(383)

(331)

回購普通股

 

(80,443)

與股份獎勵淨結算相關的支付的稅額

 

(22,239)

(21,263)

籌集資金的淨現金流量

 

(1,850)

113,759

匯率變動對現金的影響

 

125

593

現金及現金等價物的淨增加(減少)

 

5,841

(10,300)

現金及現金等價物—期初餘額

 

76,750

95,353

現金及現金等價物—期末餘額

$

82,591

$

85,053

現金流量補充披露:

期間支付的淨現金

利息

$

5,455

$

5,231

所得稅

$

6,795

$

13,540

請參閱附註事項的簡明合併財務報表。

7

目錄

OSI SYSTEMS,INC.及附屬公司

簡明合併財務報表附註

(未經審計)

1.報表的基礎

簡明綜合財務報表包括OSI Systems,Inc.及其子公司的帳戶。所有重要的公司間帳戶和交易在合併中已被消除。簡明綜合財務報表是由管理層按照美國通用會計原則(「GAAP」)和與美國證券交易委員會(「SEC」)的規則和法規一起編制的。根據SEC的規則和法規以及適用於未經審計的中期財務報表的GAAP要求,某些年度財務報表所需的信息和腳註披露已被簡化或排除。因此,簡明綜合財務報表不包括GAAP要求的所有年度財務報表所需的信息和腳註。據管理層意見,簡明綜合財務報表反映了出於公平呈現中期所示結果而被認爲是必要的常規性質的所有調整。這些建議的簡明綜合財務報表和所附說明應與我們2024財年截至6月30日的已向SEC提交的10-k表格年度報告中包括的審計合併財務報表和所附說明一起閱讀。2024年9月30日結束的三個月的運營結果不一定能體現預期的2025財年整個期間或任何未來期間的運營結果。

使用估計

根據GAAP要求編制符合會計準則的基本財務報表,需要管理層對資產和負債的報告金額、與規定的資產和負債有關的披露,以及銷售金額、銷售成本和報表期間費用的金額進行估計和假設。由於涉及到估計和假設,對於我們公司來說,最重要的估計和假設涉及合同收入、企業併購中取得的資產的公允價值和承擔的負債、按成本或淨可變現價值較低報告的存貨價值、以市場爲基礎的股票補償費用、所得稅、應計質保費用、有關的考慮、壞賬準備、以及長期資產、可識別無形資產和商譽的計量、有用壽命和估計金額的回收性等。估計的變化將在知曉的期間內反映。由於估計涉及的固有不確定性,我們未來報告的實際金額與估計金額可能有實質差異。

每股收益計算

我們通過將歸屬於普通股股東的淨利潤除以期間內普通股平均股數來計算基本每股收益。我們通過將歸屬於普通股股東的淨利潤除以期間內普通股平均股數和潛在稀釋性普通股數的和來計算稀釋每股收益。潛在普通股包括根據庫藏股法行使股票期權和限制性股票單元獎勵而發行的股份。基礎權益組成部分 2.252029年到期的可轉換高級票據(「2029年票據」)在簡明合併財務報表的第8號註解中討論,當我們的普通股平均價格超過每股轉換價$時,將對稀釋每股收益產生淨影響191.98 由於2029年債券的本金金額在兌換時以現金結算。截至2024年9月30日止三個月,2029年債券並無稀釋效應。

下表列出基本每股收益和攤薄每股收益的計算(以千爲單位,除每股金額外):

    

截至9月30日,三個月的結束

2023

    

2024

淨利潤可供普通股股東分配

$

12,879

$

17,936

 

16,825

16,742

股權獎勵的稀釋效應

 

350

313

稀釋後加權平均發行股份

 

17,175

17,055

基本每股收益

$

0.77

$

1.07

攤薄每股收益

$

0.75

$

1.05

由於其抗稀釋效應而被排除在稀釋每股收益之外的股份

8

22

8

目錄

現金及現金等價物

我們將所有到期日在收購日期之日起三個月或更短期限的高度流動的投資視爲現金等價物。

截至2023年和2024年6月30日,我們的現金及現金等價物總額分別爲$85.1 2024年9月30日的總額爲百萬美元。其中,大約 81%由我們的外國子公司持有,受贖回稅考慮。這些外國資金主要由我們在印度、英國、新加坡、加拿大和馬來西亞的子公司持有,而在墨西哥、埃及、印度尼西亞、阿爾巴尼亞和澳大利亞等其他國家的子公司持有較少。我們在金融機構持有超過此類金融機構的保險限額的現金;但是,我們通過利用我們認爲信用質量高的國際金融機構來降低這一風險。

金融工具的公允價值

我們的財務工具主要包括現金及現金等價物、保險公司合同、應收賬款、應付賬款、債務工具、利率互換合同和外幣遠期合同。除長期債務工具和我們的利率互換合同外,財務工具的賬面價值由於其短期到期性質而代表其公允價值。我們的長期債務工具的賬面價值被認爲近似其公允價值,因爲這些工具的利率是變量的或與我們可以獲得的當前融資利率相當。截至2024年6月30日和2024年9月30日,我們的外幣遠期合同的公允價值並不重要。

公允價值是在計量日期市場參與者之間進行有序交易時,在資產銷售或過戶負債時將收到的價格或支付的價格。"一級"類別包括在活躍市場上報價的相同資產和負債。"二級"類別包括除報價市場價格之外的可觀察輸入的資產和負債。"三級"類別包括用於公允價值衡量的估值技術是未觀察到且對公允價值測量具有重大影響的資產和負債。我們與收購相關的計提支付義務,詳見簡明合併財務報表附註10,爲公允價值衡量目的屬於"三級"類別。

我們的財務資產和負債的公允價值分別按以下方式分類(以千爲單位):

    

2024年6月30日

    

2024年9月30日

    

第一層次

    

第二層次

    

第三層次

    

總費用

    

第一層次

    

第二層次

    

第三層次

    

總費用

我公司截至2023年和2024年6月30日的外匯遠期合約的未實現收益和損失均不顯著。

$

$

49,679

$

$

49,679

$

$

52,430

$

$

52,430

資產 – 利率互換合同

$

$

4,735

$

$

4,735

$

$

676

$

$

676

Liabilities—Convertible debt

$

$

$

$

$

$

363,552

$

$

363,552

負債-附帶條件支出

$

$

$

15,375

$

15,375

$

$

$

24,246

$

24,246

衍生工具和對沖活動

我們對衍生工具的使用包括外幣遠期合約和利率互換協議。我們利用外幣遠期合約部分減輕某些資產負債表暴露,或將其用作淨投資套期保值工具,以防範短期外幣波動帶來的潛在變化。這些合約的原始到期期限最長爲三個月。我們還通過衍生工具管理利率變化風險。我們使用固定利率互換來有效地將部分變動利率付款轉換爲固定利率付款。我們不會出於投機目的使用套期保值工具。

來自我們的外幣遠期合約的淨收益或損失,並未被指定爲套期工具,將在合併利潤表中報告,截至2023年9月30日和2024年的三個月內,報告的金額並不顯著。我們外幣遠期合約的公允價值是使用標準估值模型和合同期內基於市場的可觀察性輸入進行估算的。未實現收益被確認爲資產,未實現損失被確認爲負債。截至2024年6月30日和2024年9月30日,我們持有的外幣遠期合約名義金額共計$96.4萬美元和101.7 分別爲0.1億美元和0.2百萬美元。 截至2024年6月30日和2024年9月30日,我們的外匯遠期合同未實現的收益和損失並不重要。

9

目錄

我們進行利率互換協議是爲了改善與基於擔保隔夜融資利率(「SOFR」)債務相關的利息支付的現金流可預測性。該利率互換於2026年12月到期。利率互換被視爲有效的現金流量套期保值,並且因此,該工具上的淨收益或損失作爲其他綜合收益(損失)的組成部分,在我們的合併財務報表中報告,並在被套期限的基礎利率影響盈利時重新分類爲淨利潤。利率互換套期保值的定性和定量評估每季度進行一次,除非事實和情況表明對沖可能不再高度有效。

截至2024年6月30日和2024年9月30日,被指定爲利率互換套期保值的衍生工具名義金額爲$ million。175 截至2024年6月30日和2024年9月30日,利率互換合同的公允價值記錄在合併資產負債表的其他資產中。

現金流量套期保值對其他綜合收益(損失)和收益的影響如下所示:

    

截至9月30日,三個月的結束

2023

    

2024

在壓縮的合併利潤表中呈現的總利息和其他費用淨額中記錄了現金流避險的影響

$

(5,748)

$

(7,359)

其他綜合收益(損失)(稅後淨額)

1,147

(3,220)

從累積其他綜合收益(損失)重新分類的金額,淨利息費用

872

900

最近的會計聲明

偶爾,由財務會計準則委員會(「FASB」)和其他監管機構發佈新的會計準則,這些準則將在指定的生效日期採納。除非另有討論,管理層認爲,尚未生效的最近發佈的準則對我們的合併財務報表在採納後不會產生重大影響。在2025財年第一季度,沒有采納新的準則。

2023年11月,FASB發佈了《2013-07號會計準則更新》,即《關於報告性部門披露的改進》(ASU 2023-07),該更新要求按部門披露重大費用,並要求揭示此前要求的年度披露項的中期披露。ASU 2023-07要求按照追溯制度應用,並於2023年12月15日後開始的財年和2024年12月15日後開始的財年內的中期披露中生效,允許提前採納。我們正在評估ASU 2023-07對我們合併財務報表中披露的潛在影響。

2023年12月,FASB發佈了《2013-09號會計準則更新》,即《關於所得稅披露的改進》(ASU 2023-09),主要涉及額外披露主要與所得稅率調和和所得稅支付有關。ASU 2023-09要求實體每年披露所得稅率調和,使用金額和百分比,考慮到包括州和地方所得稅、外國稅收影響、稅收抵免或不可抵稅項目等多個調和項目類別。披露的調和項目受數量門檻限制,並按性質和司法管轄區分開。ASU 2023-09還要求向聯邦、州和外國司法管轄區披露淨所得稅支付或獲得的信息,以及按照各司法管轄區披露,受到5%的數量門檻限制。ASU 2023-09可以按照前瞻性或追溯性採納,並於2024年12月15日後開始的財年生效,允許提前採納。我們正在評估ASU 2023-09對我們合併財務報表中披露的潛在影響。

10

目錄

2。業務組合

在會計準則編纂主題805下, 業務合併 (「ASC 805」),收購會計方法要求我們按收購之日的估計公允價值記錄收購的資產減去收購所承擔的負債。總估計收購價格超過所收購淨資產的估計公允價值的任何部分都應記作商譽。此類估值要求管理層做出重要的估計和假設,尤其是對無形資產的估值和假設。對某些無形資產進行估值的重要估計包括但不限於來自併購客戶的未來預期現金流、收購的技術、商品名稱、使用壽命和貼現率。管理層對公允價值的估計基於假設,這些假設被認爲是合理的,但本質上是不確定和不可預測的,因此,實際業績可能與估計有所不同。在自收購之日起最長一年的公允價值計量期內,隨着收購之日存在的其他信息的出現,我們可能會記錄對收購的初步資產和承擔的負債的調整。計量期結束後,任何後續調整均包含在收益中。

2025 財年業務收購

2024 年 9 月,我們(通過我們的安全部門)收購了 100一家提供關鍵軍事、太空和監視解決方案的私人控股供應商普通股的百分比,價格約爲美元76.0 百萬,再加上最多 $24.0 百萬美元的潛在或有對價。我們支付了 $75.5 交易結束時現金爲百萬美元,並記錄的滯留負債爲美元0.5 百萬美元,預計將在本財政年度結束前支付。爲本次收購支付的現金由我們的信貸額度借款融資。或有對價的收購日公允價值爲 $9.7 百萬美元,因此,加上收盤時支付的現金金額和滯留金額,總收購對價爲美元85.7 百萬美元,已分配給所購資產和承擔負債的初步公允價值。收購總資產的初步收購日期公允價值爲 $115.0 百萬其中包括 $ 的應收賬款29.8 百萬美元,庫存和其他流動資產5.9 百萬美元,財產和設備7.0 百萬,商譽爲美元28.4 百萬美元和其他無形資產43.9 百萬。出於所得稅的目的,本次業務收購確認的商譽不可扣除。其他無形資產包括美元的可攤銷無形資產35.9 百萬,攤還期爲 710 年了 以及無限期的美元無形資產8.0 百萬。初步收購日假設總負債的公允價值爲 $29.3 百萬,其中包括遞延所得稅負債 $8.4 百萬美元,主要是由於收購其他無形資產而確認的。收購資產的初步估值、承擔的負債和收購中的或有對價有待修訂。如果有其他信息,我們可能會在可行的情況下儘快進一步修改初步的收購價格分配,但不得遲於收購之日起一年。該收購業務的收入爲 $4.0 從收購之日起至2024年9月30日爲百萬美元。

2024 財年業務收購

2023 年 12 月,我們(通過我們的光電子和製造部門)以約美元的價格收購了一傢俬人合同製造商6.3 百萬。此次收購的資金來自手頭現金。出於所得稅的目的,本次業務收購確認的商譽可以扣除。

2023 年 10 月,我們(通過我們的安全部門)以約美元的價格收購了一傢俬營的輻射探測技術提供商2.8 百萬,再加上最多 $3.6 百萬美元的潛在或有對價。此次收購的資金來自手頭現金。出於所得稅的目的,本次業務收購確認的商譽不可扣除。

11

Table of Contents

3. Balance Sheet Details

The following tables set forth details of selected balance sheet accounts (in thousands):

June 30, 

September 30, 

Accounts receivable, net

    

2024

    

2024

Accounts receivable

$

667,227

$

706,844

Less allowance for doubtful accounts

 

(19,072)

(19,234)

Total

$

648,155

$

687,610

June 30, 

September 30, 

Inventories

    

2024

    

2024

Raw materials

$

238,086

$

242,738

Work-in-process

 

66,910

86,425

Finished goods

 

92,943

126,867

Total

$

397,939

$

456,030

June 30, 

September 30, 

Property and equipment, net

    

2024

    

2024

Land

$

15,494

$

16,125

Buildings, civil works and improvements

 

48,552

53,166

Leasehold improvements

 

13,573

15,462

Equipment and tooling

 

146,819

150,072

Furniture and fixtures

 

3,348

3,409

Computer equipment

 

22,597

23,870

Computer software

 

29,195

29,710

Computer software implementation in process

6,514

6,015

Construction in process

 

6,986

10,153

Total

 

293,078

307,982

Less accumulated depreciation and amortization

 

(179,111)

(183,369)

Property and equipment, net

$

113,967

$

124,613

Depreciation and amortization expense for property and equipment was $4.9 million and $6.7 million , respectively, for the three months ended September 30, 2023 and 2024.

4. Goodwill and Intangible Assets

The changes in the carrying value of goodwill by segment for the three-month period ended September 30, 2024 were as follows (in thousands):

Optoelectronics

and

Security

Manufacturing

Healthcare

    

Division

    

Division

    

Division

    

Consolidated

Balance as of June 30, 2024

$

232,215

$

70,807

$

48,458

$

351,480

Goodwill acquired during the period (see Note 2)

 

28,372

28,372

Foreign currency translation adjustment

 

223

1,201

168

1,592

Balance as of September 30, 2024

$

260,810

$

72,008

$

48,626

$

381,444

12

Table of Contents

Intangible assets consisted of the following (in thousands):

June 30, 2024

September 30, 2024

Gross

Gross

Carrying

Accumulated

Intangibles

Carrying

Accumulated

Intangibles

    

Value

    

Amortization

    

Net

    

Value

    

Amortization

    

Net

Amortizable assets:

Software development costs

$

79,228

$

(10,646)

$

68,582

$

83,339

$

(11,353)

$

71,986

Patents

9,116

(3,861)

5,255

9,265

(3,975)

5,290

Developed technology

70,186

(45,740)

24,446

97,284

(47,801)

49,483

Customer relationships

51,113

(41,421)

9,692

42,901

(26,051)

16,850

Total amortizable assets

 

209,643

(101,668)

107,975

232,789

(89,180)

143,609

Non-amortizable assets:

Trademarks

 

31,554

31,554

39,613

39,613

Total intangible assets

$

241,197

$

(101,668)

$

139,529

$

272,402

$

(89,180)

$

183,222

During the three months ended September 30, 2024 intangible assets of $43.9 million were included in the business acquisition described in Note 2.

Amortization expense related to intangible assets was $4.7 and $4.8 million for the three months ended September 30, 2023 and 2024, respectively.

At September 30, 2024, the estimated future amortization expense for amortizable intangible assets was as follows (in thousands):

Fiscal Year

2025 (remaining 9 months)

    

$

15,814

2026

 

17,965

2027

 

16,356

2028

 

15,532

2029

13,533

Thereafter

 

64,409

Total

$

143,609

Software development costs for software products incurred before establishing technological feasibility are charged to operations. Software development costs incurred after establishing technological feasibility are capitalized on a product-by-product basis until the product is available for general release to customers at which time amortization begins. Annual amortization, charged to cost of goods sold, is the amount computed using the ratio that current revenues for a product bear to the total current and anticipated future revenues for that product. In the event that future revenues are not estimable, such costs are amortized on a straight-line basis over the remaining estimated economic life of the product. Amortizable assets that have not yet begun to be amortized are included in Thereafter in the table above. For the three months ended September 30, 2023 and 2024, we capitalized software development costs in the amounts of $4.0 million and $4.2 million, respectively.

5. Contract Assets and Liabilities

We enter into contracts to sell products and provide services, and we recognize contract assets and liabilities that arise from these transactions. We recognize revenue and corresponding accounts receivable according to ASC Topic 606, Revenue from Contracts with Customers (“ASC 606”). When we recognize revenue in advance of the point in time at which contracts give us the right to invoice a customer, we record this as unbilled revenue, which is included in accounts receivable, net, on the consolidated balance sheets. We may also receive consideration, per the terms of a contract, from customers prior to transferring control of goods to the customer. We record customer deposits as contract liabilities. Additionally, we may receive payments, most typically under service and warranty contracts, at the onset of the contract and before services have been performed. In such instances, we record a deferred revenue liability in either Other accrued expenses and current liabilities or Other long-term liabilities. We recognize these contract liabilities as sales after all revenue recognition criteria are met.

13

Table of Contents

The table below shows the balance of contract assets and liabilities as of June 30, 2024 and September 30, 2024, including the change between the periods. There were no substantial non-current contract assets for the periods presented.

Contract Assets (in thousands)

    

June 30, 

    

September 30, 

    

    

 

    

2024

    

2024

    

Change

    

% Change

 

Unbilled revenue (included in accounts receivable, net)

$

338,944

$

346,589

$

7,645

2

%

Contract Liabilities (in thousands)

    

June 30, 

    

September 30, 

    

    

 

    

2024

    

2024

    

Change

    

% Change

Advances from customers

$

53,431

$

63,996

$

10,565

20

%

Deferred revenue—current

 

46,855

56,880

10,025

21

%

Deferred revenue—long-term

 

22,809

23,750

941

4

%

Contract Assets. Contract assets increased by approximately $7.6 million due to $27.9 million from the business acquisition described in Note 2, partially offset by decreases in unbilled revenue primarily from the achievement of certain milestones in our Security division which gives us the right to invoice customers.

Remaining Performance Obligations. Remaining performance obligations related to ASC 606 represent the portion of the transaction price allocated to performance obligations under an original contract with a term greater than one year which are fully or partially unsatisfied at the end of the period. As of September 30, 2024, the portion of the transaction price allocated to remaining performance obligations was approximately $805.2 million. We expect to recognize revenue on approximately of the remaining performance obligations over the next 12 months, and the remainder is expected to be recognized thereafter. During the three months ended September 30, 2024, we recognized revenue of $32.5 million from contract liabilities existing at the beginning of the period.

Practical Expedients. In cases where we are responsible for shipping after the customer has obtained control of the goods, we have elected to treat the shipping activities as fulfillment activities rather than as separate performance obligations. Additionally, we have elected to capitalize the cost to obtain a contract only if the period of amortization would be longer than one year. We only give consideration to whether a customer agreement has a financing component if the period of time between transfer of goods and services and customer payment is greater than one year.

6. Leases

The components of operating lease expense were as follows (in thousands):

Three Months Ended September 30, 

    

2023

    

2024

Operating lease cost

$

2,805

$

2,813

Variable lease cost

265

194

Short-term lease cost

325

497

$

3,395

$

3,504

14

Table of Contents

Supplemental disclosures related to operating leases were as follows (in thousands):

    

Balance Sheet Category

    

June 30, 2024

    

September 30, 2024

Operating lease right of use (“ROU”) assets, net

 

Other assets

$

30,040

$

28,994

Operating lease liabilities, current portion

 

Other accrued expenses and current liabilities

$

9,706

$

9,745

Operating lease liabilities, long-term

 

Other long-term liabilities

21,127

20,042

Total operating lease liabilities

$

30,833

$

29,787

Weighted average remaining lease term

3.6 years

Weighted average discount rate

4.6

%

Supplemental cash flow information related to operating leases was as follows (in thousands):

    

Three Months Ended September 30, 

    

2023

    

2024

Cash paid for operating lease liabilities

$

2,994

$

2,895

ROU assets obtained in exchange for new lease obligations

 

1,791

252

Maturities of operating lease liabilities at September 30, 2024 were as follows (in thousands):

    

September 30, 2024

Less than one year

$

10,840

1 – 2 years

 

9,407

2 – 3 years

 

6,821

3 – 4 years

 

2,533

4 – 5 years

 

1,272

Thereafter

 

1,432

 

32,305

Less: imputed interest

 

(2,518)

Total lease liabilities

$

29,787

7. Restructuring and Other Charges

We endeavor to align our global capacity and infrastructure with demand by our customers and to effectively integrate acquisitions and thereby improve our operational efficiency.

During the three months ended September 30, 2024, we recognized $1.2 million in restructuring and other charges, which included $0.6 million for employee terminations, $0.2 million for facility closure costs for operational efficiency activities, and $0.4 million in acquisition related costs.

During the three months ended September 30, 2023, we recognized $0.5 million in restructuring and other charges, which included $0.1 million in legal charges, $0.1 million for employee terminations, $0.1 million for facility closure costs for operational efficiency activities, and $0.2 million in acquisition related costs.

15

Table of Contents

The following tables summarize restructuring and other charges for the periods set forth below (in thousands):

Three Months Ended September 30, 2023

    

    

Optoelectronics and

    

    

    

Manufacturing

Healthcare

    

Security Division

    

Division

    

Division

    

Corporate

    

Total

Acquisition-related costs

$

208

$

$

$

$

208

Employee termination costs

13

110

123

Facility closures/consolidation

 

51

51

Legal costs, net

 

52

32

84

Total

$

273

$

51

$

$

142

$

466

Three Months Ended September 30, 2024

Optoelectronics and

Manufacturing

Healthcare

    

Security Division

    

Division

    

Division

    

Corporate

    

Total

Acquisition-related costs

$

350

$

$

$

$

350

Employee termination costs

123

304

152

579

Facility closures/consolidation

6

243

249

Total

$

479

$

547

$

152

$

$

1,178

The accrued liability for restructuring and other charges is included in Other accrued expenses and current liabilities in the condensed consolidated balance sheets. The changes in the accrued liability for restructuring and other charges for the three-month period ended September 30, 2024 were as follows (in thousands):

Facility

Acquisition-

Employee

Closure/

Legal

Related 

Termination

Consolidation

Costs and

    

Costs

    

Costs

    

Cost

    

Settlements

    

Total

Balance as of June 30, 2024

$

496

$

294

$

227

$

808

$

1,825

Restructuring and other charges, net

 

350

579

249

 

1,178

Payments, adjustments and reimbursements, net

 

(503)

(762)

(276)

 

(4)

(1,545)

Balance as of September 30, 2024

$

343

$

111

$

200

$

804

$

1,458

8. Borrowings

Revolving Credit Facility

Our senior secured credit facility comprises a term loan and a $600 million revolving credit facility which mature in December 2026. The revolving credit facility includes a $300 million sub-limit for letters of credit. Under certain circumstances and subject to certain conditions, we have the ability to increase the revolving credit facility by an amount equal to the greater of $250 million or such amount as would not cause our secured leverage ratio to exceed a specified level. Borrowings under the facility bore interest at SOFR plus a margin of 1.25% as of September 30, 2024 (which margin can range from 1.0% to 1.75% based on our consolidated net leverage ratio as defined in the credit facility). Letters of credit reduce the amount available to borrow under the credit facility by their face value amount. The unused portion of the facility bore a commitment fee of 0.15% as of September 30, 2024 (which fee can range from 0.10% to 0.25% based on our consolidated net leverage ratio as defined in the credit facility). Our borrowings under the credit agreement are guaranteed by certain of our U.S.-based subsidiaries and are secured by substantially all of our assets and substantially all the assets of certain of our subsidiaries. The credit facility contains various representations and warranties, affirmative, negative and financial covenants and events of default. As of September 30, 2024, there were $259.0 million of borrowings outstanding under the revolving credit facility, $77.1 million outstanding under the letters of credit sub-facility, and $133.8 million outstanding under the term loan. As of September 30, 2024, the amount available to borrow under the revolving credit facility was $263.9 million. Loan amounts under the revolving credit facility may be borrowed, repaid and re-borrowed during the term. The principal amount of each loan is due and payable in full on the maturity date. We have the right to repay each loan in whole or in part from time to time without penalty. It is our practice to routinely borrow and repay several times per year under the revolving facility and therefore, borrowings under the revolving credit facility are included in current liabilities. As of September 30, 2024, we were in compliance with all financial covenants under this credit facility. In September 2022, we entered into an interest rate swap in order to mitigate the interest rate risk on a portion of the interest payments expected to be made on the borrowings outstanding under the revolving credit facility and term loan. Refer to Note 1 for details.

16

Table of Contents

2.25% Convertible Senior Notes Due 2029

In July 2024, we issued an aggregate of $350.0 million principal amount of 2.25% convertible senior notes due in August 2029 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended, at an issuance price equal to 97.5% of the principal amount. The 2029 Notes were issued pursuant to and are governed by an indenture dated July 19, 2024 The proceeds from the issuance of the 2029 Notes were $340.4 million, net of the issuance discount and debt issuance costs.

The 2029 Notes are unsecured obligations which bear regular interest at 2.25% per annum payable semiannually in arrears on February 1 and August 1 of each year, beginning on February 1, 2025. The 2029 Notes will mature on August 1, 2029, unless repurchased, redeemed, or converted in accordance with their terms prior to such date. The 2029 Notes are convertible into a combination of cash and shares of our common stock, at an initial conversion rate of 5.2090 shares of common stock per $1,000 principal amount of 2029 Notes, which is equivalent to an initial conversion price of approximately $191.98 per share of our common stock. The default settlement method is a combination settlement with a specified dollar amount of $1,000 per $1,000 principal amount of notes. The conversion rate is subject to customary adjustments for certain dilutive events. We may redeem for cash all or any portion of the 2029 Notes, at our option, on or after August 6, 2027 if the last reported sale price of our common stock has been at least 130% of the conversion price then in effect for at least 20 trading days at a redemption price equal to 100% of the principal amount of the 2029 Notes to be redeemed, plus accrued and unpaid interest up to the day before the redemption date. The holders may require us to repurchase the 2029 Notes upon the occurrence of certain fundamental change transactions at a redemption price equal to 100% of the principal amount of the 2029 Notes redeemed, plus accrued and unpaid interest up to the day before the redemption date.

Holders of the 2029 Notes may convert all or a portion of their 2029 Notes at their option prior to May 1, 2029, in multiples of $1,000 principal amounts, only under the following circumstances (i) during any calendar quarter commencing after the quarter ended on September 30, 2024 (and only during such calendar quarter), if our common stock price exceeds 130% of the conversion price for at least 20 trading days during the 30 consecutive trading days at the end of the prior calendar quarter; (ii) during the five consecutive business days immediately after any 10 consecutive trading day period in which the trading price per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price per share of our common stock on such trading day and the conversion rate on such trading day; (iii) upon the occurrence of specified corporate events or certain distributions on our common stock; or (iv) if we call any or all 2029 Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date, but only with respect to the notes called for redemption.

On or after May 1, 2029, the 2029 Notes are convertible at any time until the close of business on the second scheduled trading day immediately preceding the maturity date. Holders of the 2029 Notes who convert the 2029 Notes in connection with a make-whole fundamental change, as defined in the indenture governing the 2029 Notes, or in connection with a redemption may be entitled to an increase in the conversion rate.

We accounted for the issuance of the 2029 Notes as a single liability measured at its amortized cost, as no other embedded features require bifurcation and recognition as derivatives. The following table is a summary of the 2029 Notes as of September 30, 2024 (in thousands):

    

September 30,

2024

Principal amount

$

350,000

Unamortized debt discount and issuance costs

 

(9,201)

Net carrying amount

$

340,799

Fair value (Level 2)

$

363,552

The 2029 Notes were not eligible for conversion as of September 30, 2024. No sinking fund is provided for the 2029 Notes, which means that we are not required to redeem or retire them periodically. As of September 30, 2024 we were in compliance with applicable covenants under the indenture governing the 2029 Notes.

For the three months ended September 30, 2024, total interest expense for the 2029 Notes was $1.9 million, which consisted of $1.6 million of contractual interest expense and $0.3 million of amortization of debt discount and issuance costs. The unamortized debt issuance cost is amortized on the effective interest method over the life of the 2029 Notes.

17

Table of Contents

Other Borrowings

Several of our foreign subsidiaries maintain bank lines of credit, denominated in local currencies and U.S. dollars, primarily for the issuance of letters of credit. As of September 30, 2024, $55.9 million was outstanding under these letter-of-credit facilities. As of September 30, 2024, the total amount available under these credit facilities was $30.3 million.

Long-term debt consisted of the following (in thousands):

    

June 30, 

September 30, 

    

2024

    

2024

Term loan

$

135,625

$

133,750

2029 Notes, net

340,799

Other long-term debt

 

1,925

1,752

 

137,550

476,301

Less current portion of long-term debt

 

(8,167)

(8,217)

Long-term portion of debt

$

129,383

$

468,084

Future principal payments of long-term debt by fiscal year as of September 30, 2024 are as follows (in thousands):

2025 (9 months remaining)

    

$

6,137

2026

 

8,157

2027

 

121,058

2028

 

147

2029 and thereafter

 

340,802

Total

$

476,301

9. Stockholders’ Equity

Stock-based Compensation

As of September 30, 2024, we maintained the Amended and Restated 2012 Incentive Award Plan (the “OSI Plan”) as a stock-based employee compensation plan.

We recorded stock-based compensation expense in the consolidated statements of operations as follows (in thousands):

Three Months Ended September 30, 

    

2023

    

2024

Cost of goods sold

$

232

$

244

Selling, general and administrative

6,731

6,024

Research and development

126

154

Stock-based compensation expense

$

7,089

$

6,422

As of September 30, 2024, total unrecognized compensation cost related to share-based compensation grants under the OSI Plan were estimated at $0.7 million for stock options and $18.4 million for restricted stock units (“RSUs”). We expect to recognize these costs over a weighted average period of 1.8 years with respect to the stock options and 2.3 years with respect to the RSUs.

18

Table of Contents

The following summarizes stock option activity during the three months ended September 30, 2024:

Weighted

Average

Weighted-Average

Aggregate

Number of

Exercise

Remaining Contractual

Intrinsic Value

    

Options

    

Price

    

Term

    

(in thousands)

Outstanding at June 30, 2024

 

78,958

 

$

97.87

 

Granted

 

Exercised

 

(957)

69.64

Expired or forfeited

 

Outstanding at September 30, 2024

 

78,001

$

105.17

7.4 years

$

4,182

Exercisable at September 30, 2024

33,690

$

89.06

 

6.0 years

$

2,115

The following summarizes RSU award activity during the three months ended September 30, 2024:

Weighted-

Average

    

Shares

    

Fair Value

Nonvested at June 30, 2024

 

391,591

$

99.21

Granted

 

253,256

95.41

Vested

 

(297,418)

130.64

Forfeited

 

(2,400)

98.75

Nonvested at September 30, 2024

 

345,029

$

106.76

As of September 30, 2024, there were approximately 2.1 million shares available for grant under the OSI Plan. Under the terms of the OSI Plan, RSUs granted from the pool of shares available for grant reduce the pool by 1.87 shares for each award granted. RSUs forfeited and returned to the pool of shares available for grant increase the pool by 1.87 shares for each award forfeited.

We granted 75,988 and 54,563 performance-based RSUs during the three months ended September 30, 2023 and 2024, respectively. These performance-based RSU awards are contingent on the achievement of certain performance metrics. The payout related to these awards can range from zero to 376% of the original number of shares or units awarded. Compensation cost associated with these performance based RSUs are recognized based on the estimated number of shares that we ultimately expect will vest. If the estimated number of shares to vest is revised in the future, then stock-based compensation expense will be adjusted accordingly.

Stock Repurchase Program

In September 2022, our Board of Directors increased the stock repurchase authorization to a total of 2 million shares. This program does not expire unless our Board of Directors acts to terminate the program. The timing and actual numbers of shares purchased depends on a variety of factors, including stock price, general business and market conditions and other investment opportunities. Repurchases may be made from time to time under the program through open-market purchases or privately-negotiated transactions at our discretion. Upon repurchase, the shares are restored to the status of authorized but unissued shares, and we record them in our consolidated financial statements as a reduction in the number of shares of common stock issued and outstanding, with the excess purchase price over par value recorded as a reduction of additional paid-in capital. If additional paid-in capital is reduced to zero, we record the remainder of the excess purchase price over par value as a reduction of retained earnings.

During the three months ended September 30, 2024, we repurchased 531,314 shares of common stock for an aggregate purchase price of approximately $80 million. As of September 30, 2024, there were 1,190,556 shares remaining available for repurchase under the authorized repurchase program.

Dividends

We have not paid any dividends since the consummation of our initial public offering in 1997 and we do not currently intend to pay any dividends in the foreseeable future. Our Board of Directors will determine the payment of future dividends, if any. Certain of our current bank credit facilities restrict the payment of dividends and future borrowings may contain similar restrictions.

19

Table of Contents

10. Commitments and Contingencies

Acquisition-Related Contingent Obligations

Under the terms and conditions of the purchase agreements associated with certain acquisitions, we may be obligated to make additional payments based on the achievement of certain sales or profitability milestones through the acquired operations. For agreements that contain contingent consideration obligations that are capped, the remaining maximum amount of such potential future payments is $56.8 million as of September 30, 2024.

Projections and estimated probabilities are used to estimate future contingent earnout payments, which are discounted back to present value to compute contingent earnout liabilities. The following table provides a roll-forward from June 30, 2024 to September 30, 2024 of the contingent consideration liability, which is included in Other accrued expenses and current liabilities and other long-term liabilities in our consolidated balance sheets (in thousands):

Beginning fair value, June 30, 2024

    

$

15,375

Business acquisition (Note 2)

9,730

Foreign currency translation adjustment

188

Changes in fair value for contingent earnout obligations

 

(716)

Payments on contingent earnout obligations

 

(331)

Ending fair value, September 30, 2024

$

24,246

Environmental Contingencies

We are subject to various environmental laws. We conduct environmental investigations at our manufacturing facilities in North America, Asia-Pacific, and Europe, and, to the extent practicable, on all new properties in order to identify, as of the date of such investigation, potential areas of environmental concern related to past and present activities or from nearby operations. In certain cases, we have conducted further environmental assessments consisting of soil and groundwater testing and other investigations deemed appropriate by independent environmental consultants.

We have not accrued for loss contingencies relating to environmental matters because we believe that, although unfavorable outcomes are possible, they are not considered by our management to be probable and reasonably estimable. If one or more of these environmental matters are resolved in a manner adverse to us, the impact on our business, financial condition, results of operations and cash flow could be material.

Indemnifications and Certain Employment-Related Contingencies

In the normal course of business, we have agreed to indemnify certain parties with respect to certain matters. We have agreed to hold certain parties harmless against losses arising from a breach of representations, warranties or covenants, or intellectual property infringement or other claims made by third parties. These agreements may limit the time within which an indemnification claim can be made and the amount of the claim. In addition, we have entered into indemnification agreements with our directors and certain of our officers. It is not possible to determine the maximum potential amount under these indemnification agreements due to, among other factors, the limited history of prior indemnification claims and the unique facts and circumstances involved in each particular agreement. We have not recorded any liability for costs related to contingent indemnification obligations as of September 30, 2024.

Product Warranties

We offer our customers warranties on many of the products that we sell. These warranties typically provide for repairs and maintenance of the products if problems arise during a specified time period after original shipment. Concurrent with the sale of products, we record a provision for estimated warranty expenses with a corresponding increase in cost of goods sold. We periodically adjust this provision based on historical experience and anticipated expenses. We charge actual expenses of repairs under warranty, including parts and labor, to this provision when incurred. The current obligation for warranty provision is included in other accrued expenses and current liabilities and the noncurrent portion is included in other long-term liabilities in the consolidated balance sheets.

20

Table of Contents

The following table presents changes in warranty provisions (in thousands):

Three Months Ended September 30, 

    

2023

    

2024

Balance at beginning of period

$

11,149

$

11,089

Additions

312

988

Reductions for warranty repair costs and adjustments

 

(902)

(719)

Balance at end of period

$

10,559

$

11,358

Legal Proceedings

In February 2023, one of our subsidiaries received a subpoena from the U.S. Department of Justice (“DoJ”). The subpoena was issued as part of a DoJ case against a former employee of an OSI Systems subsidiary for embezzlement and other conduct occurring before he was hired by our subsidiary and while he was employed by another company in the United States and Mexico. The subpoena requests documents and records relating to, among other things, the former employee and the Company’s business dealings in Mexico since 2020. In February 2024, we received a follow-up subpoena requesting the same categories of documents but extending the relevant time period through to the date of the second subpoena. We have produced documents in response to these subpoenas and intend to cooperate with any further subpoenas or other requests in connection with this or any ensuing investigation. In September 2024, we received a subpoena requesting records relating to certain entities in Honduras. Consistent with past practice, we intend to cooperate with requests arising from this most recent subpoena.

We are involved in various other potential or actual claims and legal proceedings arising in the ordinary course of business. In our opinion after consultation with legal counsel, the ultimate disposition of such proceedings is not likely to have a material adverse effect on our business, financial condition, results of operations or cash flows. We have not accrued for loss contingencies relating to any non-ordinary course matters because we believe that, although unfavorable outcomes in the proceedings are possible, they are not considered by management to be probable and reasonably estimable. If one or more of these matters are resolved in a manner adverse to our Company, the impact on our business, financial condition, results of operations and cash flows could be material.

11. Income Taxes

The determination of the annual effective tax rate is based upon a number of significant estimates and judgments, including the estimated annual pretax income in each tax jurisdiction in which we operate and the development of tax planning strategies during the year. In addition, as a global commercial enterprise, our tax expense can be impacted by changes in tax rates or laws, the finalization of tax audits and reviews and other factors that cannot be predicted with certainty. As such, there can be significant volatility in interim tax provisions.

The effective tax rates for the three months ended September 30, 2023 and 2024 were 23.4% and 21.9%, respectively. During the three months ended September 30, 2023 and 2024, we recognized a net discrete tax benefit of $0.4 million and $0.5 million, respectively, related to equity-based compensation under ASU 2016-09.

21

Table of Contents

12. Segment Information

We have determined that we operate in three identifiable industry segments: (a) security and inspection systems (Security division), (b) optoelectronic devices and manufacturing (Optoelectronics and Manufacturing division) and (c) medical monitoring systems (Healthcare division). We also have a corporate segment (Corporate) that includes executive compensation and certain other general and administrative expenses, expenses related to stock issuances and legal, audit and other professional service fees not allocated to industry segments. Both the Security and Healthcare divisions comprise primarily end-product businesses, whereas the Optoelectronics and Manufacturing division primarily supplies components and subsystems to external OEM customers, as well as to the Security and Healthcare divisions. Sales between divisions are at transfer prices that approximate market values. All other accounting policies of the segments are the same as described in Note 1, Basis of Presentation.

The following tables present our results of operations and identifiable assets by industry segment (in thousands):

Three Months Ended

September 30, 

    

2023

    

2024

Revenues (1) —by Segment:

Security division

$

164,629

$

224,314

Optoelectronics and Manufacturing division, including intersegment revenues

96,128

97,795

Healthcare division

37,787

37,102

Intersegment revenues elimination

(19,334)

(15,204)

Total

$

279,210

$

344,007

Income (loss) from operations —by Segment:

Security division

$

20,609

$

28,856

Optoelectronics and Manufacturing division

11,437

10,609

Healthcare division

164

800

Corporate

(9,916)

(9,510)

Intersegment Eliminations

265

(427)

Total

$

22,559

$

30,328

June 30, 

September 30, 

    

2024

    

2024

Assets (2) —by Segment:

Security division

$

1,333,259

$

1,514,264

Optoelectronics and Manufacturing division

 

288,629

289,302

Healthcare division

255,093

255,639

Corporate

 

106,078

100,958

Eliminations (3)

 

(47,051)

(46,649)

Total

$

1,936,008

$

2,113,514

(1)For the three months ended September 30, 2023, no customer accounted for greater than 10% of total net revenues. For the three months ended September 30, 2024, one Security division customer accounted for 14% of net revenues.
(2)As of June 30, 2024, two customers in the Security division accounted for 39% and 10%, respectively, of accounts receivable, net. As of September 30, 2024, two customers in the Security division accounted for 37% and 12%, respectively, of accounts receivable, net.
(3)Eliminations in assets reflect the amount of inter-segment profits in inventory and inter-segment ROU assets under ASC 842 as of the balance sheet date. Such inter-segment profit will be realized when inventory is shipped to the external customers of the Security and Healthcare divisions.

22

Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

In this report, “OSI”, the “Company”, “we”, “us”, “our” and similar terms refer to OSI Systems, Inc. together with our wholly-owned subsidiaries.

This management’s discussion and analysis of financial condition as of September 30, 2024 and results of operations for the three months ended September 30, 2024 should be read in conjunction with management’s discussion and analysis of financial condition and results of operations included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2024 filed with the SEC.

Forward-Looking Statements

This report contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements relate to our current expectations, beliefs, and projections concerning matters that are not historical facts. Words such as “project,” “believe,” “anticipate,” “plan,” “expect,” “intend,” “may,” “should,” “will,” “would,” and similar words and expressions are intended to identify forward-looking statements. Forward-looking statements are not guarantees of future performance and involve uncertainties, risks, assumptions and contingencies, many of which are outside our control. Assumptions upon which our forward-looking statements are based could prove to be inaccurate, and actual results may differ materially from those expressed in or implied by such forward-looking statements. Important factors that could cause our actual results to differ materially from our expectations are disclosed in this report, our Annual Report on Form 10-K for the fiscal year ended June 30, 2024 (including Part I, Item 1, “Business,” Part I, Item 1A, “Risk Factors” and Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations”) and other documents filed by us from time to time with the SEC. Such factors, of course, do not include all factors that might affect our business and financial condition. We could be exposed to a variety of negative consequences as a result of delays related to the award of domestic and international contracts; failure to secure the renewal of key customer contracts; delays in customer programs; delays in revenue recognition related to the timing of customer acceptance; the impact of potential information technology, cybersecurity or data security breaches; changes in domestic and foreign government spending, budgetary, procurement and trade policies adverse to our businesses; the impact of the Russia-Ukraine conflict or conflicts in the Middle East, including the potential for broad economic disruption; global economic uncertainty; material delays and cancellations of orders or deliveries thereon, supply chain disruptions, plant closures, or other adverse impacts on our ability to execute business plans; unfavorable currency exchange rate fluctuations; effect of changes in tax legislation; market acceptance of our new and existing technologies, products and services; our ability to win new business and convert any orders received to sales within the fiscal year; contract and regulatory compliance matters, and actions, which if brought, could result in judgments, settlements, fines, injunctions, debarment or penalties; as well as other risks and uncertainties, including but not limited to those factors described in our other SEC filings. All forward-looking statements contained in this report are qualified in their entirety by this Section. Moreover, we operate in a very competitive and rapidly changing environment and new risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. Investors should not place undue reliance on forward-looking statements as a prediction of actual results. We undertake no obligation other than as may be required under securities laws to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Executive Summary

We are a vertically integrated designer and manufacturer of specialized electronic systems and components for critical applications. We sell our products and provide related services in diversified markets, including homeland security, healthcare, defense and aerospace. We have three operating divisions: (a) Security, providing security and inspection systems and turnkey security screening solutions; (b) Optoelectronics and Manufacturing, providing specialized electronic components for our Security and Healthcare divisions, as well as to third parties for applications in the defense and aerospace markets, among others; and (c) Healthcare, providing patient monitoring, cardiology and remote monitoring, and connected care systems and associated accessories.

Security Division. Security and inspection products are used in airports and at a wide range of other facilities such as border crossings, seaports, freight forwarding operations (to screen cargo before it is loaded onto airplanes and ships), government and military installations, sports and concert venues, correctional facilities, and other locations where the interdiction of criminal activities is paramount. The U.S. Department of Homeland Security has undertaken numerous initiatives to prevent terrorists from entering the

23

Table of Contents

country, hijacking airplanes, and obtaining and transporting explosives, weapons and their components, and to prevent human trafficking, among other serious crimes. These initiatives, such as the Customs-Trade Partnership Against Terrorism, the U.S. Transportation Security Administration’s Air Cargo Screening Mandate and the U.S. Customs and Border Protection Container Security Initiative, have resulted in increased demand for security and inspection products, as have similar programs undertaken by governments around the world. Revenues from our Security division accounted for 59% and 65% of our total consolidated revenues for the three months ended September 30, 2023 and 2024, respectively.

Optoelectronics and Manufacturing Division. Through our Optoelectronics and Manufacturing division, we design, manufacture and market optoelectronic devices and flex circuits and provide electronics manufacturing services globally for use in a broad range of applications, including aerospace and defense electronics, security and inspection systems, medical imaging and diagnostics, telecommunications, office automation, computer peripherals, industrial automation and consumer products. We also provide our optoelectronic devices and electronics manufacturing services to OEM customers and to our own Security and Healthcare divisions. Revenues from external customers in our Optoelectronics and Manufacturing division accounted for 28% and 24% of our total consolidated revenues for the three months ended September 30, 2023 and 2024, respectively.

Healthcare Division. Through our Healthcare division, we design, manufacture, market and service patient monitoring, cardiology and remote monitoring, and connected care systems globally for sale primarily to hospitals and medical centers. Our products monitor patients in critical, emergency and perioperative care areas of the hospital and provide information, through wired and wireless networks, to physicians and nurses who may be at the patient’s bedside, in another area of the hospital or even outside the hospital. Revenues from our Healthcare division accounted for 13% and 11% of our total consolidated revenues for the three months ended September 30, 2023 and 2024, respectively.

Trends and Uncertainties

The following is a discussion of certain trends and uncertainties that we believe have influenced, and may continue to influence, our results of operations.

Global Economic Considerations. Our products and services are sold in numerous countries worldwide, with a large percentage of our sales generated outside the United States. We are exposed to and impacted by global macroeconomic factors, U.S. and foreign government policies and foreign exchange fluctuations. There is uncertainty surrounding macroeconomic factors in the U.S. and globally characterized by supply chain disruptions, inflationary pressure, and labor shortages. Increasing diplomatic and trade friction between the U.S. and China has also created significant uncertainty in the global economy. These global macroeconomic factors, coupled with political unrest internationally and the volatile U.S. political climate, including uncertainty regarding the upcoming U.S. presidential election, have created uncertainty and impacted demand for certain of our products and services. Conflicts in Gaza and nearby regions have created political and economic uncertainty in the Middle East. Also, the continued conflict between Russia and Ukraine and the sanctions imposed in response to this conflict have increased global economic and political uncertainty. We do not know how long this uncertainty will continue. These factors could have a material adverse effect on our business, results of operations and financial condition.

Global Trade. The current domestic and international political environment, including in relation to recent and further potential changes by the U.S. and other countries in policies on global trade and tariffs, have resulted in uncertainty surrounding the future state of the global economy and global trade. This uncertainty is exacerbated by sanctions imposed by the U.S. government against certain businesses and individuals in select countries. Continued or increased uncertainty regarding global trade due to these or other factors may require us to modify our current business practices and could have a material adverse effect on our business, results of operations and financial condition.

Healthcare Considerations. Our Healthcare division experienced some increased demand for its patient monitoring products as a result of the COVID-19 pandemic during the earlier stages of the pandemic. Certain hospitals are facing significant financial pressure as supply chain constraints and inflation drive up operating costs, and higher interest rates make access to credit more expensive. Continuation of these macroeconomic conditions would likely have an adverse impact on hospitals’ spend on capital equipment and thereby could have a material adverse effect on our business, results of operations and financial condition.

Government Policies. Our results of operations and cash flows could be materially affected by changes in U.S. or foreign government legislative, regulatory or enforcement policies.

24

Table of Contents

Russia’s Invasion of Ukraine. The invasion of Ukraine by Russia and the sanctions imposed in response to this conflict have increased global economic and political uncertainty. This has the potential to indirectly disrupt our supply chain and access to certain resources. While we have not experienced significant adverse impacts to date and will continue to monitor for any impacts and seek to mitigate disruption that may arise, we have certain research and development activities within Ukraine for our Healthcare division which have been somewhat impacted. The conflict also has increased the threat of malicious cyber activity from nation states and other actors.

Currency Exchange Rates. On a year-over-year basis, currency exchange rates negatively impacted reported sales by approximately 0.7% for the three months ended September 30, 2024 compared to the three months ended September 30, 2023, primarily due to the strengthening of the U.S. dollar against other foreign currencies in 2024. Any further strengthening of the U.S. dollar against foreign currencies would adversely impact our sales for the remainder of the fiscal year, and any weakening of the U.S. dollar against foreign currencies would positively impact our sales for the remainder of the fiscal year.

Results of Operations for the Three Months Ended September 30, 2023 (Q1 Fiscal 2024) Compared to the Three Months Ended September 30, 2024 (Q1 Fiscal 2025) (amounts in millions)

Net Revenues

The table below and the discussion that follows are based upon the way in which we analyze our business. See Note 12 to the condensed consolidated financial statements for additional information about our business segments.

    

Q1

    

% of

    

Q1

    

% of

    

    

 

    

Fiscal 2024

    

Net Revenues

    

Fiscal 2025

    

Net Revenues

    

$ Change

    

% Change

 

Security

 

$

164.6

59.0

%

$

224.3

65.2

%

$

59.7

36.3

%

Optoelectronics and Manufacturing

76.8

27.5

82.6

24.0

5.8

7.6

Healthcare

37.8

13.5

37.1

10.8

(0.7)

(1.9)

Total net revenues

 

$

279.2

100

%

$

344.0

100.0

%

$

64.8

23.2

%

Revenues for the Security division during Q1 fiscal 2025 increased year-over-year due to increases in product and service revenues of approximately $52.1 million and $7.6 million, respectively. The increase in product revenues was primarily driven by growth in cargo and vehicle inspection systems, trace detections systems, checkpoint screening sales, and the acquired business further described in Note 2 to the condensed consolidated financial statements. The increase in service revenue was due primarily to an increase in the installed base of products.

Revenues for the Optoelectronics and Manufacturing division during Q1 fiscal 2025 increased year-over-year as a result of an increase in revenues in our contract manufacturing business of approximately $7.4 million, offset by a decrease in revenues in our optoelectronics business of approximately $1.6 million.

Revenues for the Healthcare division during Q1 fiscal 2025 decreased year-over-year due to lower product sales of $2.2 million, partially offset by an increase in service revenues of $1.5 million.

25

Table of Contents

Gross Profit

Q1

% of

Q1

% of

    

Fiscal 2024

    

Net Revenues

    

Fiscal 2025

    

Net Revenues

    

Gross profit

$

98.7

35.4

%

$

121.5

35.3

%

Gross profit is impacted by sales volume and changes in overall manufacturing-related costs, such as raw materials and component costs, warranty expense, provision for inventory, freight, and logistics. Gross profit increased approximately $22.8 million in Q1 fiscal 2025 as compared to the prior year driven by the increase in sales. Our cost of goods sold increased year-over-year primarily as a result of the increase in revenues.

Operating Expenses

Q1

    

% of

    

Q1

% of

    

Fiscal 2024

    

Net Revenues

    

Fiscal 2025

    

Net Revenues

    

$ Change

    

% Change

Selling, general and administrative

    

$

59.8

    

21.4

%  

$

72.2

21.0

%  

$

12.4

20.7

%

Research and development

 

15.9

 

5.7

17.8

5.2

 

1.9

11.9

Impairment, restructuring and other charges, net

 

0.5

 

0.2

1.2

0.3

 

0.7

140.0

Total operating expenses

$

76.2

 

27.3

%  

$

91.2

26.5

%  

$

15.0

19.7

%

Selling, general and administrative. Our significant selling, general and administrative (“SG&A”) expenses include employee compensation, sales commissions, travel, professional services, marketing expenses, foreign currency translation, and depreciation and amortization expense. SG&A expense for Q1 fiscal 2025 was $12.4 million higher than in the same prior-year period primarily due to unfavorable foreign currency exchange rates and an increase in employee compensation in Q1 fiscal 2025 to support the growth of the Company as compared to the same prior-year period.

Research and development. Research and development (“R&D”) expenses include research related to new product development and product enhancements. R&D expenses increased $1.9 million in Q1 fiscal 2025 as compared to Q1 fiscal 2024 driven by increased compensation costs to support new product development initiatives primarily in our Security division.

Restructuring and other charges. Restructuring and other charges generally consist of costs relating to reductions in our workforce, facilities consolidation, costs related to acquisition activity, and other non-recurring charges. During Q1 fiscal 2025, restructuring and other charges consisted of $0.4 million for acquisition activity and $0.8 million related to employee terminations, and legal and other costs. During Q1 fiscal 2024, restructuring and other charges consisted of $0.2 million for acquisition activity and $0.3 million related to employee terminations, and legal and other costs.

Interest and Other Expense, Net

Q1

% of

Q1

% of

 

    

Fiscal 2024

    

Net Revenues

    

Fiscal 2025

    

Net Revenues

 

Interest and other expense, net

$

5.7

 

2.0

%  

$

7.4

 

2.2

%

Interest and other expense, net. For Q1 fiscal 2025, interest and other expense, net was $7.4 million as compared to $5.7 million in the same prior-year period. This increase was driven by higher average levels of borrowings primarily to support the increase in working capital associated with the growth in revenues and for the repurchase of approximately $80 million of common stock in July 2024.

Income taxes. The effective tax rate for a particular period varies depending on a number of factors, including (i) the mix of income earned in various tax jurisdictions, each of which applies a unique range of income tax rates and income tax credits, (ii) changes in previously established valuation allowances for deferred tax assets (changes are based upon our current analysis of the likelihood that these deferred tax assets will be realized), (iii) the level of non-deductible expenses, (iv) certain tax elections (v) tax holidays granted to certain of our international subsidiaries and (vi) discrete tax items. For Q1 fiscal 2025 and 2024, we recognized a provision for income taxes of $5.0 million and $3.9 million, respectively. The effective tax rates for Q1 fiscal 2025 and 2024 were 21.9% and 23.4%, respectively. During Q1 fiscal 2025 and 2024, we recognized a net discrete tax benefit of $0.5 million and $0.4 million, respectively, related to equity-based compensation under ASU 2016-09.

26

Table of Contents

Liquidity and Capital Resources

Our principal sources of liquidity are our cash and cash equivalents, cash generated from operations and our credit facilities. Cash and cash equivalents totaled $85.1 million at September 30, 2024, a decrease of $10.3 million, or 11%, from $95.4 million at June 30, 2024. We currently anticipate that our available funds, credit facilities and cash flow from operations will be sufficient to meet our operational cash needs for the next 12 months and the foreseeable future beyond that. In addition, we anticipate that cash generated from operations, without repatriating earnings from our non-U.S. subsidiaries, and our credit facilities will be sufficient to satisfy our obligations in the U.S.

In July 2024, we issued an aggregate of $350.0 million principal amount of 2.25% convertible senior notes due in August 2029 In connection with the issuance of the 2029 Notes, we repurchased 531,314 shares of our common stock for approximately $80 million.

Our credit facility comprises a term loan and a $600 million revolving credit facility, which includes a $300 million sub-facility for letters of credit. As of September 30, 2024, there was $133.8 million outstanding under the term loan, $259.0 million outstanding under our revolving credit facility and $77.1 million of outstanding letters of credit. As of September 30, 2024, the total amount available under our revolving credit facility was $263.9 million. See Note 8 to the consolidated financial statements for further discussion.

Cash Provided by (Used in) Operating Activities. Cash flows from operating activities can fluctuate significantly from period to period, as net income, adjusted for non-cash items, and working capital fluctuations impact cash flows. During Q1 fiscal 2025, we used cash from operations of $37.2 million compared to cash provided by operations of $17.1 million in the comparable prior-year period. The net change in cash flows from operating activities was due primarily to a net increase in accounts receivable, inventories and other current assets in the Security division, partially offset by other changes in net working capital.

Cash Used in Investing Activities. Net cash used in investing activities was $87.5 million for Q1 fiscal 2025 as compared to $9.6 million in the same prior-year period. We used $75.5 million for a business acquisition during the three-month period ended September 30, 2024. Capital expenditures in the three-month period ended September 30, 2024 were $7.7 million compared to $5.2 million in the same prior-year period. Expenditures for intangible and other assets in the three-month period ended September 30, 2024 were $4.4 million compared to $4.2 million in the same prior-year period.

Cash Used in Financing Activities. Net cash provided by financing activities was $113.8 million during Q1 fiscal 2025, compared to $1.9 million used during the same prior-year period. The change in cash flows from financing activities was primarily due to net proceeds of $340.4 million from the 2029 Notes, partially offset by (1) net repayment of $125.0 million on our credit facility and (2) repurchase of common shares of $80.4 million. Taxes paid related to net share settlement of equity awards was $21.3 million during Q1 fiscal 2025 compared to $22.2 million in the same prior-year period.

Borrowings

See Note 8 to the condensed consolidated financial statements for a detailed discussion regarding our revolving credit facility and other borrowings.

Cash Held by Foreign Subsidiaries

Our cash and cash equivalents totaled $85.1 million at September 30, 2024. Of this amount, approximately 81% was held by our foreign subsidiaries and subject to repatriation tax considerations. These foreign funds were held primarily by our subsidiaries in the, India, UK, Singapore, Canada and Malaysia and to a lesser extent in Mexico, Egypt, Indonesia, Albania, and Australia among other countries. We intend to permanently reinvest certain earnings from foreign operations, and we currently do not anticipate that we will need this cash in foreign countries to fund our U.S. operations. In the event we repatriate cash from certain foreign operations and if taxes have not previously been withheld on the related earnings, we would provide for withholding taxes at the time we change our intention with regard to the reinvestment of those earnings.

27

Table of Contents

Issuer Purchases of Equity Securities

The following table contains information about the shares of common stock we purchased during the quarter ended September 30, 2024:

    

    

    

    

    

    

Maximum number (or

approximate dollar

value) of

Total number of

shares (or

shares (or units)

units)

purchased as

that may

Total number of

Average price

part of publicly

yet be purchased

shares (or units)

paid per share (or

announced plans or

under the plans or

    

purchased

    

unit)

    

programs

    

programs (1)

July 1 to July 31, 2024

 

531,314

$

150.57

 

531,314

 

1,190,556

August 1 to August 31, 2024

 

$

 

 

1,190,556

September 1 to September 30, 2024

 

$

 

 

1,190,556

 

531,314

 

531,314

(1)In September 2022, when there were 1,131,301 shares remaining authorized to repurchase under the then-existing share repurchase program, the Board of Directors renewed the authorization and revised the maximum number of shares to 2,000,000 shares authorized under the stock repurchase program. Upon repurchase, shares of common stock are restored to the status of authorized but unissued shares, and we record them as a reduction in the number of shares of common stock issued and outstanding in our consolidated financial statements.

Contractual Obligations

During the first quarter of fiscal year 2025, there were no material changes outside the ordinary course of business to the information regarding specified contractual obligations contained in our Annual Report on Form 10-K for the fiscal year ended June 30, 2024. See Notes 1, 6, 8 and 10 to the condensed consolidated financial statements for additional information regarding our contractual obligations.

Recent Accounting Pronouncements

From time to time, new accounting pronouncements are issued by the FASB and other regulatory bodies that are adopted as of the specified effective dates. Unless otherwise discussed, management believes that the impact of recently issued standards, which are not yet effective, will not have a material impact on our Consolidated Financial Statements upon adoption. As discussed in Note 1, we are currently evaluating the potential impact on financial statement disclosures upon future adoption of ASU 2023 - 07 and ASU 2023 - 09. There were no new pronouncements adopted in the first quarter of fiscal year 2025.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

For a discussion of our exposure to market risk, refer to our market risk disclosures set forth in Part II, Item 7A “Quantitative and Qualitative Disclosures About Market Risk” in our Annual Report on Form 10-K for the fiscal year ended June 30, 2024. There have been no material changes in our exposure to market risk during the three months ended September 30, 2024 from that described in the Annual Report.

28

Table of Contents

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

As of September 30, 2024, the end of the period covered by this report, our management, including our Chief Executive Officer and our Chief Financial Officer, reviewed and evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) or 15d-15(e) of the Exchange Act). Based upon management’s review and evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of the period covered by this Quarterly Report on Form 10-Q, our disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified by the SEC and is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting during the first quarter of fiscal 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Limitations on Effectiveness of Controls and Procedures

In designing and evaluating our controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud within the Company have been detected.

29

Table of Contents

PART II—OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

From time to time, we are subject to litigation and other legal proceedings and claims  arising in the ordinary course of our business or otherwise. More information regarding legal proceedings in which we are involved can be found under Note 10, “Commitments and Contingencies” of the Notes to the Consolidated Financial Statements in Part I, Item 1 of this Report, which is incorporated by reference into this Item 1.

ITEM 1A. RISK FACTORS

The discussion of our business, financial condition and results of operations in this Quarterly Report on Form 10-Q for the period ended September 30, 2024 should be read together with the risk factors contained in our Annual Report on Form 10-K for the fiscal year ended June 30, 2024, filed with the SEC on August 29, 2024, which describe various risks and uncertainties that could materially affect our business, financial condition and results of operations in the future. There have been no material changes to the risk factors included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2024.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

See Issuer Purchases of Equity Securities discussion under Part I, Item 2 - Management’s Discussion and Analysis of Financial Condition and Results of Operations, which is incorporated by reference into this Item 2.

In July 2024, we issued an aggregate of $350.0 million principal amount of 2.25% convertible senior notes due in August 2029. The 2029 Notes were issued to the initial purchasers in reliance upon Section 4(a)(2) of the Securities Act in transactions not involving any public offering. The 2029 Notes were resold by the initial purchasers to persons whom the initial purchasers reasonably believe are “qualified institutional buyers,” as defined in, and in accordance with, Rule 144A under the Securities Act. Any shares of our common stock that may be issued upon conversion of the 2029 Notes will be issued in reliance upon Section 3(a)(9) of the Securities Act as involving an exchange by us exclusively with our security holders. Initially, a maximum of 2,324,490 shares of our common stock may be issued upon conversion of the 2029 Notes based on the initial maximum conversion rate of 6.6414 shares of common stock per $1,000 principal amount of 2029 Notes which is subject to customary anti-dilution adjustment provisions.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable

ITEM 5. OTHER INFORMATION

Our directors and officers (as defined in Rule 16a-1 under the Exchange Act) may from time to time enter into plans or other arrangements for the purchase or sale of our shares that are intended to satisfy the affirmative defense conditions of Rule 10b5-1 (c) or may represent a non-Rule 10b5-1 trading arrangement under the Exchange Act. During the first quarter of fiscal 2025, none of our directors or officers informed us of the adoption, modification or termination of a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement” as those terms are defined in Regulation S-K, Item 408.

30

Table of Contents

ITEM 6. EXHIBITS

Exhibit
Number

    

Description

4.1

Indenture, dated as of July 19, 2024, between OSI Systems, Inc. and U.S. Bank Trust Company, National Association, as trustee (1)

4.2

Form of certificate representing the 2.25% Convertible Senior Notes due 2029 (included as Exhibit A to Exhibit 4.1) (1)

31.1

Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2

Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1

Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2

Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS

XBRL Instance Document

101.SCH

Inline XBRL Taxonomy Extension Schema

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase

104

Cover Page Interactive Data File (formatted as Inline XBRL with applicable taxonomy extension information contained in Exhibits 101)

(1)Previously filed with our Current Report on Form 8-K filed on July 19, 2024.

31

Table of Contents

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized, in the City of Hawthorne, State of California on the 25th day of October 2024.

OSI SYSTEMS, INC.

By:

/s/ Deepak Chopra

Deepak Chopra

President and Chief Executive Officer

(Principal Executive Officer)

By:

/s/ Alan Edrick

Alan Edrick

Executive Vice President and Chief Financial Officer

(Principal Financial Officer)

By:

/s/ Cary Okawa

Cary Okawa

Chief Accounting Officer

(Principal Accounting Officer)

32